CONTINUOUS INFUSION OR INTRAVENOUS BOLUS - WHAT IS THE RATIONALE FOR DOXORUBICIN ADMINISTRATION

被引：22

作者：

ROBERT, J

机构：

来源：

CANCER DRUG DELIVERY | 1987年 / 4卷 / 03期

关键词：

D O I：

10.1089/cdd.1987.4.191

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：191 / 199

页数：9

共 52 条

[21]

HASKELL CM, 1974, CANCER RES, V34, P2991

[22] THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER [J].

HRYNIUK, W ;

BUSH, H .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) :1281-1288

[23] TUMOR-CELL RESISTANCE TO ANTHRACYCLINES - A REVIEW [J].

KAYE, S ;

MERRY, S .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) :96-103

[24] REDUCTION OF DOXORUBICIN CARDIOTOXICITY BY PROLONGED CONTINUOUS INTRAVENOUS-INFUSION [J].

LEGHA, SS ;

BENJAMIN, RS ;

MACKAY, B ;

EWER, M ;

WALLACE, S ;

VALDIVIESO, M ;

RASMUSSEN, SL ;

BLUMENSCHEIN, GR ;

FREIREICH, EJ .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) :133-139

[25]

LEGHA SS, 1982, CANCER, V49, P1762, DOI 10.1002/1097-0142(19820501)49:9<1762::AID-CNCR2820490905>3.0.CO

[26]

2-Q

[27] DAUNOMYCIN ADMINISTERED BY CONTINUOUS INTRAVENOUS-INFUSION IS EFFECTIVE IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA [J].

LEWIS, JP ;

MEYERS, FJ ;

TANAKA, L .

BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (02) :261-265

[28]

LOKICH J, 1982, CANCER, V50, P2731, DOI 10.1002/1097-0142(19821215)50:12<2731::AID-CNCR2820501206>3.0.CO

[29]

2-P

[30] CONSTANT INFUSION SCHEDULE FOR ADRIAMYCIN - A PHASE-I-II CLINICAL-TRIAL OF A 30-DAY SCHEDULE BY AMBULATORY PUMP DELIVERY SYSTEM [J].

LOKICH, J ;

BOTHE, A ;

ZIPOLI, T ;

GREEN, R ;

SONNEBORN, H ;

PAUL, S ;

PHILIPS, D .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (01) :24-28

← 1 2 3 4 5 6 →